Reaction

Heparin-Induced Thrombocytopenia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 4,884 reports · 118 co-occurring drugs

As of the last recalculation, Heparin-Induced Thrombocytopenia appears in 4,884 FAERS reports alongside 118 co-occurring drug terms. The strongest observed disproportionality signal is HEPARIN SODIUM (PRR 533.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Heparin Sodium	1,273	533.2	587.8
Fondaparinux Sodium	122	65.9	66.9
Enoxaparin Sodium	637	54.1	54.7
Dalteparin Sodium	95	39.0	39.4
Norepinephrine	59	23.8	23.9
Norepinephrine Bitartrate	79	23.8	23.9
Cefazolin	37	17.4	17.5
Cefazolin Sodium	41	14.6	14.7
Dextrose Monohydrate	44	14.1	14.2
Dextrose	43	14.0	14.1
Warfarin Sodium	145	13.7	13.7
Piperacillin Sodium And Tazobactam Sodium	62	13.6	13.7
Magnesium Sulfate In Water For	36	12.1	12.1
Magnesium Sulfate Heptahydrate	36	11.9	11.9
Magnesium Sulfate	36	11.8	11.9
Cefepime	37	11.1	11.1
Phytonadione	21	10.6	10.6
Cefepime Hydrochloride	39	10.4	10.4
Warfarin	287	10.2	10.2
Vancomycin	134	10.1	10.2
Alteplase	34	9.7	9.7
Bisacodyl Suppositories	28	9.3	9.3
Biscodyl	28	9.2	9.2
Vancomycin Hydrochloride	138	9.2	9.2
Piperacillin And Tazobactam	27	9.0	9.1
Bisacodyl	28	8.5	8.5
Ampicillin	16	8.3	8.3
Ampicillin Sodium	16	8.3	8.3
Propofol	67	7.9	7.9
Insulin	100	7.8	7.8
Amiodarone Hydrochloride	19	7.3	7.3
Calcium Gluconate	19	6.7	6.8
Ceftriaxone	50	6.6	6.6
Diphenhydramine Hcl	17	6.5	6.5
Epoetin Alfa	18	6.5	6.5
Ticagrelor	48	6.5	6.5
Piperacillin Sodium,Tazobactam Sodium	39	6.3	6.3
Ceftriaxone Sodium	56	6.3	6.3
Chlorhexidine Gluconate	13	6.1	6.1
Ipratropium Bromide	50	6.0	6.0
Clopidogrel Bisulfate	135	5.8	5.8
Sodium Bicarbonate	31	5.7	5.7
Sodium Bicarbonate Injection,	31	5.7	5.7
Nitroglycerin	69	5.5	5.6
Potassium Chloride, Dextrose Monohydrate	117	5.5	5.5
Potassium Chloride Oral	117	5.5	5.5
Potassium Chloride Extended-Release	117	5.5	5.5
Meropenem	40	5.3	5.4
Remdesivir	16	5.1	5.1
Sennosides 8.6 Mg Tablets	25	5.1	5.1
Senna	25	5.1	5.1
Adrenalinum	49	5.1	5.1
Senna Leaf	27	5.0	5.0
Enalapril Maleate	29	5.0	5.0
Acetylcysteine	11	5.0	5.0
Magnesium Hydroxide	15	4.8	4.8
Morphine	81	4.7	4.7
Gentamicin	14	4.6	4.6
Potassium Chloride	118	4.5	4.5
Cefuroxime	12	4.5	4.5
Captopril	10	4.4	4.4
Metronidazole	65	4.4	4.4
Gentamicin Sulfate	16	4.3	4.3
Lidicaine	49	4.3	4.3
Burn Relief	49	4.3	4.3
Lidocaine Hydrochloride And Epinephrine	49	4.3	4.3
Docusate Sodium - Sennosides	32	4.3	4.3
Lidocaine, Menthol	49	4.2	4.2
Sennosides	29	4.2	4.2
Metronidazole Topical	46	4.1	4.1
Digoxin	69	4.1	4.1
Atropine	8	4.1	4.1
Clopidogrel	185	4.1	4.1
Lidocaine Hydrochloride And Epinephrine Bitartrate	50	4.0	4.0
Docusate Sodium	53	3.9	3.9
Isosorbide Dinitrate	18	3.9	3.9
Lidocaine 4%	49	3.9	3.9
Mupirocin	12	3.8	3.8
Docusate Sodium 100Mg	21	3.8	3.8
Linezolid	26	3.7	3.7
Mupirocin Calcium	12	3.7	3.7
Apixaban	58	3.7	3.7
Phenytoin	18	3.7	3.7
Midazolam Hydrochloride	23	3.7	3.7
Metoroprolol Tartrate	56	3.6	3.7
Lidocaine	49	3.6	3.6
Epoprostenol	11	3.6	3.6
Midazolam	21	3.6	3.6
Lidocaine Hydrochloride	50	3.6	3.6
Atropine Sulfate	9	3.6	3.6
Furosemide	316	3.5	3.5
Fluconazole	54	3.3	3.3
Aspirin 325 Mg	372	3.3	3.3
Aspirin 81 Mg	372	3.3	3.3
Rocuronium Bromide	9	3.3	3.3
Epinephrine	49	3.2	3.2
Aspirin	375	3.1	3.1
Sodium Chloride	57	3.1	3.1
Human Insulin	9	3.1	3.1
Metolazone	8	3.0	3.0
Micafungin Sodium	6	3.0	3.0
Fentanyl	69	3.0	3.0
Felodipine Extended-Release Tablets	8	3.0	3.0
Felodipine	8	3.0	3.0
Dexamethasone Sodium Phosphate	7	2.9	2.9
Tamsulosin Hydrochloride	14	2.9	2.9
Erythropoietin	14	2.9	2.9
Metoprolol Tartrate	180	2.9	2.9
Sodium Chloride Tablet	49	2.9	2.9
Dapagliflozin	21	2.9	2.9
Sodium Chloride Tablets	48	2.8	2.8
Quinapril Hydrochloride	5	2.7	2.7
Prasugrel Hydrochloride	6	2.5	2.5
Insulin Human	20	2.1	2.1
Irinotecan Hydrochloride	6	2.0	2.0
Fentanyl Citrate	8	1.9	1.9
Paricalcitol	4	1.2	1.2
Methoxy Polyethylene Glycol-Epoetin Beta	3	1.2	1.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.